Literature DB >> 26457621

Genetic variability in ABCB1, occupational pesticide exposure, and Parkinson's disease.

Shilpa Narayan1, Janet S Sinsheimer2, Kimberly C Paul1, Zeyan Liew1, Myles Cockburn3, Jeff M Bronstein4, Beate Ritz5.   

Abstract

BACKGROUND: Studies suggested that variants in the ABCB1 gene encoding P-glycoprotein, a xenobiotic transporter, may increase susceptibility to pesticide exposures linked to Parkinson's Disease (PD) risk.
OBJECTIVES: To investigate the joint impact of two ABCB1 polymorphisms and pesticide exposures on PD risk.
METHODS: In a population-based case control study, we genotyped ABCB1 gene variants at rs1045642 (c.3435C/T) and rs2032582 (c.2677G/T/A) and assessed occupational exposures to organochlorine (OC) and organophosphorus (OP) pesticides based on self-reported occupational use and record-based ambient workplace exposures for 282 PD cases and 514 controls of European ancestry. We identified active ingredients in self-reported occupational use pesticides from a California database and estimated ambient workplace exposures between 1974 and 1999 employing a geographic information system together with records for state pesticide and land use. With unconditional logistic regression, we estimated marginal and joint contributions for occupational pesticide exposures and ABCB1 variants in PD.
RESULTS: For occupationally exposed carriers of homozygous ABCB1 variant genotypes, we estimated odds ratios of 1.89 [95% confidence interval (CI): (0.87, 4.07)] to 3.71 [95% CI: (1.96, 7.02)], with the highest odds ratios estimated for occupationally exposed carriers of homozygous ABCB1 variant genotypes at both SNPs; but we found no multiplicative scale interactions.
CONCLUSIONS: This study lends support to a previous report that commonly used pesticides, specifically OCs and OPs, and variant ABCB1 genotypes at two polymorphic sites jointly increase risk of PD.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Epidemiology; Multidrug resistance protein 1 gene (ABCB1); P-glycoprotein; Parkinson’s disease; Pesticide

Mesh:

Substances:

Year:  2015        PMID: 26457621      PMCID: PMC4911423          DOI: 10.1016/j.envres.2015.08.022

Source DB:  PubMed          Journal:  Environ Res        ISSN: 0013-9351            Impact factor:   6.498


  51 in total

1.  Detection of gene-environment interaction by case-only studies.

Authors:  N Hamajima; H Yuasa; K Matsuo; Y Kurobe
Journal:  Jpn J Clin Oncol       Date:  1999-10       Impact factor: 3.019

2.  Organochlorine insecticides in substantia nigra in Parkinson's disease.

Authors:  F M Corrigan; C L Wienburg; R F Shore; S E Daniel; D Mann
Journal:  J Toxicol Environ Health A       Date:  2000-02-25

3.  MDR1 C3435T polymorphism and interaction with environmental factors in risk of Parkinson's disease: a case-control study in Japan.

Authors:  Chikako Kiyohara; Yoshihiro Miyake; Midori Koyanagi; Takahiro Fujimoto; Senji Shirasawa; Keiko Tanaka; Wakaba Fukushima; Satoshi Sasaki; Yoshio Tsuboi; Tatsuo Yamada; Tomoko Oeda; Hiroyuki Shimada; Nobutoshi Kawamura; Nobutaka Sakae; Hidenao Fukuyama; Yishio Hirota; Masaki Nagai
Journal:  Drug Metab Pharmacokinet       Date:  2012-09-11       Impact factor: 3.614

4.  Functional evidence for P-glycoprotein at the nose-brain barrier.

Authors:  Candace L Graff; Gary M Pollack
Journal:  Pharm Res       Date:  2005-01       Impact factor: 4.200

5.  The association between ambient exposure to organophosphates and Parkinson's disease risk.

Authors:  Anthony Wang; Myles Cockburn; Thomas T Ly; Jeff M Bronstein; Beate Ritz
Journal:  Occup Environ Med       Date:  2014-01-16       Impact factor: 4.402

6.  Calbindin 1, fibroblast growth factor 20, and alpha-synuclein in sporadic Parkinson's disease.

Authors:  Ikuko Mizuta; Tatsuhiko Tsunoda; Wataru Satake; Yuko Nakabayashi; Masahiko Watanabe; Atsushi Takeda; Kazuko Hasegawa; Kenji Nakashima; Mitsutoshi Yamamoto; Nobutaka Hattori; Miho Murata; Tatsushi Toda
Journal:  Hum Genet       Date:  2008-06-22       Impact factor: 4.132

7.  Permeability and toxicological profile estimation of organochlorine compounds by biopartitioning micellar chromatography.

Authors:  L Escuder-Gilabert; R M Villanueva-Camañas; S Sagrado; M J Medina-Hernandez
Journal:  Biomed Chromatogr       Date:  2009-04       Impact factor: 1.902

8.  Expression polymorphism of the blood-brain barrier component P-glycoprotein (MDR1) in relation to Parkinson's disease.

Authors:  Taku Furuno; Maria-Teresa Landi; Mauro Ceroni; Neil Caporaso; Ilaria Bernucci; Giuseppe Nappi; Emilia Martignoni; Elke Schaeffeler; Michel Eichelbaum; Matthias Schwab; Ulrich M Zanger
Journal:  Pharmacogenetics       Date:  2002-10

9.  Association of a polymorphism in the ABCB1 gene with Parkinson's disease.

Authors:  Marie Westerlund; Andrea Carmine Belin; Anna Anvret; Anna Håkansson; Hans Nissbrandt; Charlotta Lind; Olof Sydow; Lars Olson; Dagmar Galter
Journal:  Parkinsonism Relat Disord       Date:  2009-02-03       Impact factor: 4.891

10.  Analysis of MDR1 haplotypes in Parkinson's disease in a white population.

Authors:  Eng-King Tan; Marek Drozdzik; Monika Bialecka; Krystyna Honczarenko; Gabriela Klodowska-Duda; Y Y Teo; Kun Tang; Li-Peng Wong; Samuel S Chong; Chris Tan; Kenneth Yew; Yi Zhao; Caroline Gl Lee
Journal:  Neurosci Lett       Date:  2004-12-06       Impact factor: 3.046

View more
  11 in total

1.  Coffee consumption is associated with DNA methylation levels of human blood.

Authors:  Yu-Hsuan Chuang; Austin Quach; Devin Absher; Themistocles Assimes; Steve Horvath; Beate Ritz
Journal:  Eur J Hum Genet       Date:  2017-02-15       Impact factor: 4.246

Review 2.  Of Pesticides and Men: a California Story of Genes and Environment in Parkinson's Disease.

Authors:  Beate R Ritz; Kimberly C Paul; Jeff M Bronstein
Journal:  Curr Environ Health Rep       Date:  2016-03

Review 3.  Assessing health risks from multiple environmental stressors: Moving from G×E to I×E.

Authors:  Cliona M McHale; Gwendolyn Osborne; Rachel Morello-Frosch; Andrew G Salmon; Martha S Sandy; Gina Solomon; Luoping Zhang; Martyn T Smith; Lauren Zeise
Journal:  Mutat Res Rev Mutat Res       Date:  2017-11-24       Impact factor: 5.657

Review 4.  Transporters as Drug Targets in Neurological Diseases.

Authors:  H Qosa; L A Mohamed; S Alqahtani; B S Abuasal; R A Hill; A Kaddoumi
Journal:  Clin Pharmacol Ther       Date:  2016-08-27       Impact factor: 6.875

5.  Genetic association of NOS1 exon18, NOS1 exon29, ABCB1 1236C/T, and ABCB1 3435C/T polymorphisms with the risk of Parkinson's disease: A meta-analysis.

Authors:  Hongbin Huang; Cong Peng; Yong Liu; Xu Liu; Qicong Chen; Zunnan Huang
Journal:  Medicine (Baltimore)       Date:  2016-10       Impact factor: 1.889

6.  Inflammatory and cytotoxic effects of bifenthrin in primary microglia and organotypic hippocampal slice cultures.

Authors:  Brahim Gargouri; Nizar M Yousif; Michèle Bouchard; Hamadi Fetoui; Bernd L Fiebich
Journal:  J Neuroinflammation       Date:  2018-05-24       Impact factor: 8.322

Review 7.  Membrane transporter data to support kinetically-informed chemical risk assessment using non-animal methods: Scientific and regulatory perspectives.

Authors:  Laure-Alix Clerbaux; Alicia Paini; Annie Lumen; Hanan Osman-Ponchet; Andrew P Worth; Olivier Fardel
Journal:  Environ Int       Date:  2019-03-08       Impact factor: 9.621

Review 8.  Preventing Parkinson's Disease: An Environmental Agenda.

Authors:  Briana R De Miranda; Samuel M Goldman; Gary W Miller; J Timothy Greenamyre; E Ray Dorsey
Journal:  J Parkinsons Dis       Date:  2022       Impact factor: 5.568

Review 9.  Genetic Profile, Environmental Exposure, and Their Interaction in Parkinson's Disease.

Authors:  Letizia Polito; Antonio Greco; Davide Seripa
Journal:  Parkinsons Dis       Date:  2016-01-31

10.  Prevention of pesticide-induced neuronal dysfunction and mortality with nucleophilic poly-Oxime topical gel.

Authors:  Ketan Thorat; Subhashini Pandey; Sandeep Chandrashekharappa; Nikitha Vavilthota; Ankita A Hiwale; Purna Shah; Sneha Sreekumar; Shubhangi Upadhyay; Tenzin Phuntsok; Manohar Mahato; Kiran K Mudnakudu-Nagaraju; Omprakash Sunnapu; Praveen K Vemula
Journal:  Sci Adv       Date:  2018-10-17       Impact factor: 14.136

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.